cancer diagnosis
Breast cancer
common cancer
cancer cells
aggressive HER2 cancer
available cancer diagnostic
SDS-OmiProbe device
novel SDS-OmiProbe
OmiProbe target market of HER2
challenges of SoA cancer markers diagnosis
SDS Optic
objective results
targeted therapy tools
targeted therapy drugs
HER2 marker tests
Revolutionary opto-biological methodology
quantitative results
new cases
year
women
Current diagnosis methods of cancers
high volume market
Transparency Market Research
significant levels of discordance
biomarker tests
laboratory analysis
laboratory test
breast tumours
breakthrough device
measures concentration levels
companion diagnostic tool
significant global business opportunity
expensive biopsy
rapid growth trend
extracting tissue samples
World Health Organization
realization of independent clinical trials
greater accuracy
dissemination
instant cellular processes studies
project
landscape
presence
optimization
potential
efficacy
single-cell resolution
biopsies
leading causes of morbidity
striking gap
compelling evidence
mortality
tip
order
essence
disease